InvestorsHub Logo
Followers 5
Posts 296
Boards Moderated 0
Alias Born 01/20/2020

Re: None

Saturday, 10/03/2020 10:54:24 AM

Saturday, October 03, 2020 10:54:24 AM

Post# of 426842
does anyone have an explanation for why FDA required Teva to add infringing info on patented indication to their skinny label in 2011? Is there a specific rule explaining why this happened? Obviously Hikma etc currently have a skinny label for IPE without CVD
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News